Institute for Health Metrics & Evaluation: 2015 Insights

The Institute for Health Metrics and Evaluation (IHME) released its Global Burden of Disease (GBD) study in 2015, providing a comprehensive, detailed, and up-to-date assessment of the global distribution and causes of death, disease, and disability. This annual report, published in The Lancet, is a culmination of the efforts of over 1,800 researchers from 126 countries, making it one of the most extensive collaborative scientific studies to date.

Key Findings of the 2015 GBD Study

The 2015 GBD study brought forth several significant findings that have profound implications for global health policy and resource allocation. Here are some of the key takeaways:

• Global Life Expectancy: The global life expectancy at birth increased from 66.3 years in 1990 to 71.7 years in 2015. However, this increase was not uniform across all regions, with some countries experiencing significant improvements while others stagnated or even regressed.
• Leading Causes of Death: The top five causes of death worldwide in 2015 were ischaemic heart disease, stroke, chronic obstructive pulmonary disease, lower respiratory infections, and lung cancer. These diseases accounted for over 17 million deaths, or 30% of all deaths globally.
• Disability-Adjusted Life Years (DALYs): The total number of DALYs, a measure of overall disease burden, decreased by 16.5% between 1990 and 2015. However, this decline was not consistent across all causes of death and disease, with some non-communicable diseases showing an increase in DALYs.

Regional Disparities in Health Outcomes

One of the most striking findings of the 2015 GBD study was the vast disparities in health outcomes between and within countries. While some countries, such as Japan and Switzerland, had life expectancies over 80 years, others, like Sierra Leone and Chad, had life expectancies under 55 years. These disparities were not limited to low-income countries; significant health gaps were also observed between states within high-income countries like the United States.

Increasing Burden of Non-Communicable Diseases

The 2015 GBD study highlighted the growing burden of non-communicable diseases (NCDs) worldwide. NCDs, which include cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes, accounted for 70% of all deaths globally in 2015. This proportion has increased steadily since 1990, reflecting the global epidemiological transition towards more age-related, chronic diseases. The study emphasized the need for a greater focus on prevention and treatment of NCDs, particularly in low- and middle-income countries where resources are often prioritized for infectious diseases.

Impact of Injuries and Violence

Injuries, including those resulting from road traffic accidents, violence, and self-harm, accounted for over 5 million deaths in 2015. The burden of injuries was highest in low-income and middle-income countries, with road traffic injuries being a particular problem in many regions. The study called for increased efforts to prevent injuries and improve trauma care, particularly in low-resource settings.

Methodological Advancements in the 2015 GBD Study

The 2015 GBD study introduced several methodological improvements, enhancing the accuracy and precision of its estimates. These advancements included the use of new data sources, improved statistical modeling techniques, and a more comprehensive assessment of uncertainty. The study also expanded its coverage to include new causes of death and disease, as well as new risk factors, providing a more complete picture of the global health landscape.

The Institute for Health Metrics and Evaluation's 2015 Global Burden of Disease study provided invaluable insights into the distribution and causes of death, disease, and disability worldwide. By highlighting regional disparities, the increasing burden of non-communicable diseases, and the impact of injuries and violence, the study underscored the urgent need for targeted, evidence-based health interventions. The methodological advancements in the 2015 study also paved the way for future research, ensuring that global health policy is informed by the best available data.